Homechevron_rightArchiveschevron_rightHealth

Archives

Explore Stories by Date

Today

77% of Psychologists Report Patients Using AI Chatbots for Mental Health Support, APA Survey Finds

A new American Psychological Association survey of over 1,200 licensed psychologists reveals that three-quarters have patients using AI chatbots for emotional support, self-diagnosis, and companionship. While some report positive outcomes, 36% of psychologists noticed patients developing dependency on chatbots, and 15% observed distorted thinking or delusions.

2 Sources

Yesterday

Stanford grads raise $11M to build noninvasive wearable for continuous hormone tracking

Clair Health, founded by 21-year-old Jenny Duan and Abhinav Agarwal, secured $11.6 million in seed funding led by Khosla Ventures to develop what they call the first continuous non-invasive hormone monitor for women. The wearable uses 10 biosensors including a novel biomagnetic sensor to track hormonal health, targeting conditions like perimenopause, PCOS, and endometriosis with a November launch planned at $369.

2 Sources

AI analyzes retinal photos to predict Alzheimer's disease risk decades before symptoms appear

University of Florida researchers trained machine learning models on retinal photographs from over 40,000 patients to identify early Alzheimer's disease risk factors. The AI-powered analysis detected biological and lifestyle indicators like blood pressure, smoking, and insomnia by examining the retina's arteries and optic nerve, offering a low-cost alternative to expensive brain scans.

2 Sources

JMIR Publications explores AI clinical reasoning and digital fatigue in modern healthcare

JMIR Publications released two feature stories examining AI's role in healthcare. One explores how OpenAI's o1 model matched physician performance in clinical decision-making across three care stages. The other investigates digital fatigue in modern health care, where administrative burdens from digital systems contribute to healthcare worker burnout despite automation benefits.

2 Sources

16 Jun 2026

Brain-Computer Interface and AI Let Speechless ALS Patient Speak and Work Full-Time

A UC Davis brain-computer interface has enabled Casey Harrell, a paralyzed ALS patient, to communicate independently for over 3,800 hours across two years with 99% accuracy in controlled tests. Using AI-driven speech synthesis, the BCI implant translates neural activity into speech, allowing him to work full-time as an environmental advocate and have conversations with his daughter who's never heard his voice.

2 Sources

AI-powered deep brain stimulation adapts in real time to improve gait in Parkinson's disease

Researchers have developed adaptive deep brain stimulation that adjusts electrical pulses in real time based on patient movement. The system uses machine learning to decode brain signals during walking, standing, and obstacle navigation, delivering personalized neuromodulation that improves walking in Parkinson's patients where conventional therapies fall short.

3 Sources

15 Jun 2026

Family blames AI hospital system after woman dies waiting five days for ICU bed in Brazil

A 32-year-old Brazilian woman died after an AI-powered hospital management system allegedly delayed her ICU transfer for five days. Rebeca Cardoso Tenente Molina's family claims the Core-MG system assigned her a lower severity score than her deteriorating condition warranted, preventing doctors from exercising their medical judgment. The case highlights concerns about AI decision-making in critical healthcare situations.

2 Sources

11 Jun 2026

Takeda's AI-developed psoriasis pill outperforms Bristol Myers' Sotyktu in head-to-head trial

Takeda Pharmaceutical announced its AI-crafted experimental psoriasis drug zasocitinib achieved superior skin clearance compared to Bristol Myers' approved Sotyktu in a late-stage study. The once-daily pill delivered complete skin clearance in 35% of patients after 16 weeks, more than 2.5 times Sotyktu's rate, positioning it as a potential blockbuster with projected peak annual sales of $3-6 billion.

2 Sources

Abridge and Nvidia build foundation model for clinical intelligence from real doctor visits

Abridge unveiled an AI-native clinician intelligence platform with backing from Nvidia and Eli Lilly, transforming ambient AI from a transcription tool into an operating system for medicine. The startup now processes 100 million clinical conversations annually across 300+ health systems, while co-developing the first foundation model trained specifically on doctor-patient dialogue.

3 Sources

10 Jun 2026

Hetairos AI classifies brain tumors in 12 minutes with 87% accuracy, outperforming specialists

Researchers at the German Cancer Research Center have developed Hetairos, an AI system that identifies over 100 molecular subtypes of brain tumors using standard microscopic tissue sections. Trained on more than 11,000 slides from 9,606 patients across four continents, the system delivers diagnoses in 12 minutes with 87% accuracy—significantly outperforming experienced neuropathologists in head-to-head testing.

2 Sources

09 Jun 2026

Machine learning model plasmaCHORD filters biological noise to improve liquid biopsy accuracy

Researchers at Johns Hopkins Kimmel Cancer Center developed plasmaCHORD, a machine learning model that distinguishes tumor mutations from white blood cell mutations in liquid biopsy samples. The model improved accuracy from approximately 50% to 83% for clinically relevant mutations, helping clinicians select more effective targeted cancer treatments and avoid therapies unlikely to work.

2 Sources

Common joint supplement glucosamine linked to 25% faster Alzheimer's progression in new study

University of Florida researchers discovered that glucosamine, a widely used over-the-counter joint supplement, is associated with a 25% higher likelihood of progressing from mild cognitive impairment to Alzheimer's disease. The study analyzed 12 years of health records and found the supplement may worsen disease progression in millions of seniors who take it for joint pain.

2 Sources

AI screening tool boosts diabetic eye exam referrals for African Americans by 46%

Johns Hopkins researchers found that African American patients with diabetes were significantly more likely to receive diabetic eye exam referrals when screened with an FDA-approved AI tool compared to traditional primary care provider referrals. The AI-assisted diagnostic tool analyzed retinal images in real time, providing immediate results that increased patient adherence to essential screenings for diabetic retinopathy.

2 Sources

06 Jun 2026

New AI technology speeds eye disease diagnosis and predicts heart attack, stroke risks from retinal scans

Researchers at Washington University School of Medicine developed OCTCube-M, an AI system that analyzes 3D eye scans to detect retinal diseases more accurately than older models. The technology identified 43 to 60 additional cases per 1,000 individuals and can predict broader health risks including heart attack, stroke, and kidney failure based solely on retinal imaging.

2 Sources

05 Jun 2026

New AI tool achieves near-perfect accuracy in distinguishing Alzheimer's from Lewy body dementia

University of Florida researchers developed AIDD, an AI-powered tool that combines brain scans with machine learning to distinguish between Alzheimer's disease and dementia with Lewy bodies with near-perfect accuracy. The breakthrough addresses a critical problem: up to 50% of Lewy body dementia patients are misdiagnosed as having Alzheimer's, leading to treatments that can worsen symptoms.

2 Sources

Get all updates into your inbox 💌, Stay Up-to-date for Free 🥳

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.

Explore

News Categories

Technology Business Policy Startups Health Science Entertainment

Terms Privacy Content Contact Us